Prognosis of acute coronary syndromes after radiotherapy for breast cancer.

[1]  P. Erne,et al.  Treatment of patients with myocardial infarction depends on history of cancer , 2018, European heart journal. Acute cardiovascular care.

[2]  S. Darby,et al.  Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer , 2018, British Journal of Cancer.

[3]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[4]  R. Jagsi,et al.  Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices. , 2017, International journal of radiation oncology, biology, physics.

[5]  Jeroen J. Bax,et al.  Different manifestation of irradiation induced coronary artery disease detected with coronary computed tomography compared with matched non-irradiated controls. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[7]  S. Darby,et al.  Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005 , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  G. Lip,et al.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). , 2016, European heart journal.

[9]  Jens Overgaard,et al.  DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Michael Hauptmann,et al.  Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Holmberg,et al.  Radiation dose distribution in coronary arteries in breast cancer radiotherapy , 2016, Acta oncologica.

[12]  D. Rietveld,et al.  Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. , 2016, International journal of radiation oncology, biology, physics.

[13]  Zhe Wang,et al.  Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013. , 2015, International journal of radiation oncology, biology, physics.

[14]  Laurence Collette,et al.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. , 2015, The New England journal of medicine.

[15]  T. Sio,et al.  Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer. , 2014, JACC. Cardiovascular interventions.

[16]  R. Peto,et al.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[17]  EBCTCG (Early Breast Cancer Trialists' Collaborati.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[18]  G. Stone,et al.  Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. , 2013, American heart journal.

[19]  F. Stewart,et al.  Thalidomide is not able to inhibit radiation-induced heart disease , 2013, International journal of radiation biology.

[20]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.

[21]  F. A. Stewart.  Mechanisms and dose-response relationships for radiation-induced cardiovascular disease , 2012, Annals of the ICRP.

[22]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[23]  J. Durand,et al.  Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population , 2012, Clinical cardiology.

[24]  Hans Garmo,et al.  Distribution of coronary artery stenosis after radiation for breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[26]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[27]  P. Hall,et al.  Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  Per Hall,et al.  Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001 , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  F. Stewart,et al.  NO-Donating Aspirin and Aspirin Partially Inhibit Age-Related Atherosclerosis but Not Radiation-Induced Atherosclerosis in ApoE Null Mice , 2010, PloS one.

[30]  O. Dalesio,et al.  Novel insights into pathological changes in muscular arteries of radiotherapy patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  W. Desmet,et al.  Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study , 2010, Heart.

[32]  C. Stiller,et al.  Second primary neoplasms in survivors of Wilms' tumour—A population‐based cohort study from the British Childhood Cancer Survivor Study , 2008, International journal of cancer.

[33]  Andrew Nisbet,et al.  Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. , 2007, International journal of radiation oncology, biology, physics.

[34]  J. Reitsma,et al.  Incidence of first acute myocardial infarction in the Netherlands. , 2007, The Netherlands journal of medicine.

[35]  A. Kastrati,et al.  Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[36]  H. Bartelink,et al.  Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. , 2007, Journal of the National Cancer Institute.

[37]  Wei-Ting Hwang,et al.  Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Klijn,et al.  Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. , 2006, International journal of radiation oncology, biology, physics.

[39]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[40]  M S Pepe,et al.  Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.

[41]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .

[42]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[43]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .